MedTrace Logo

Daily Target Guided Radiation Therapy Using the Calypso 4D Localization System in Patients Who Have Had a Prostatectomy for Prostate Cancer

NCT01624623 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2015-09-11

No results posted yet for this study

Summary

This study will evaluate the daily use of a unique daily organ tracking system on target localization in patients treated with radiation therapy after radical prostatectomy for prostate cancer.

Improved coverage of the target volume with radiotherapy could result in improved cancer control rates and decreased coverage of surrounding structures potentially decreasing treatment toxicity.

Conditions

Sponsors & Collaborators

  • U.S. Army Medical Research Acquisition Activity

    lead FED

Principal Investigators

  • Dusten Macdonald, MD · Department of the Army

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2016-05-31
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01624623 on ClinicalTrials.gov